Much-maligned regional bank Synovus Financial (NYSE: SNV ) reported first-quarter earnings this morning, and it pretty much went as expected. With consensus estimates pegging the Georgia bank at $0.02 earnings per share, Synovus didn't disappoint and met that number, and the stock has risen in trading today.
This year truly could be a make or break year for the bank. With nearly $1 billion in TARP obligations still impeding its performance, the bank really needed to show impressive progress in order to pay off those obligations as planned by the third quarter. Did the bank start the year off on the right foot? Or will it be playing catch up in quarters to come?
So far, so good
The first quarter pre-tax income of $46.6 million was the highest the bank has seen in nearly five years. This would not have been possible without significant reductions in the cost of credit and expenses.Credit costs also reached their lowest levels in five years, down to $49.3 million for the quarter. This was a substantial decrease from the first quarter of last year, which came in at $90.9 million.�
Top India Stocks To Buy For 2015: Fidia SpA (FDA)
Fidia SpA is an Italy-based company primarily engaged in the production of numerical controls and machine tools. The Company�� activities are divided into three main business lines. In the High-speed Milling Systems, it is involved in the production and sale of milling heads kits and cutting-edge equipment. Through the Numerical Controls, Dives and Software sector, it is active in the manufacture of numerical controls for milling systems, as well as in the development and distribution of computer-aided design (CAD) and computer-aided manufacturing (CAM) software. The After-sales Service sector includes the provision of technical services, sale of spare parts and scheduled maintenance contracts. The Company operates in Germany, France, Brazil, China, Poland and India, among others. Advisors' Opinion:- [By Steven Silver]
Its Apremilast is currently under Food and Drug Administration (FDA) review for the anti-inflammatory condition, psoriatic arthritis, and has also shown promise in such indications as psoriasis and ankylosing spondylitis.
- [By Patricio Kehoe]
Despite recent anti-tobacco laws passed by the European Union and the Food and Drug Administration (FDA) in the U.S, the company�� pricing power has helped maintain its margins. In 2012, for example, Phillip Morris hiked prices on its products in Russia, Germany, Belgium, Canada, France, Greece and Spain, among others. Although the necessary measure caused substantial volume declines in these countries, consumers rapidly became accustomed to the increased prices, and returned to their habitual product consumption. Given the success of this strategy, the firm is likely to rely on it in Japan for 2014, where taxes are expected to increase yet again by 8%, after the 40% spike in October 2010.
Top 5 Regional Bank Companies To Buy For 2014: Transcept Pharmaceuticals Inc.(TSPT)
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product is the Intermezzo, a low dose sublingual formulation of zolpidem as a sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States. It is also developing TO-2061, a low dose ondansetron adjunctive therapy, which is in Phase II study for patients with obsessive-compulsive disorder. The company was founded in 2002 and is based in Point Richmond, California.
Advisors' Opinion:- [By Roberto Pedone]
Transcept Pharmaceuticals (TSPT) is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. This stock closed up 6% to $2.98 in Thursday's trading session.
Thursday's Range: $2.81-$2.99
52-Week Range: $2.77-$6.77
Thursday's Volume: 138,000
Three-Month Average Volume: 158,095From a technical perspective, TSPT spiked sharply higher here right above some near-term support at $2.77 and back above its 50-day moving average at $2.95 with decent upside volume. This move is quickly pushing shares of TSPT within range of triggering a major breakout trade. That trade will hit if TSPT manages to take out some near-term overhead resistance levels at $3.16 to $3.25 with high volume. If that breakout hits, it would also push TSPT outside of a large consolidation pattern the stock has been in for the last three months.
Traders should now look for long-biased trades in TSPT as long as it's trending above some key near-term support at $2.77 and then once it sustains a move or close above those breakout levels with volume that hits near or above 158,095 shares. If that breakout triggers soon, then TSPT will set up to re-test or possibly take out its next major overhead resistance levels at $4.23 to its 200-day moving average at $4.50. Any high-volume move above those levels will then put $4.89 to $5 into range for shares of TSPT.
- [By Roberto Pedone]
An under-$10 biotech stock that's trending very close to triggering a near-term breakout trade is Transcept Pharmaceuticals (TSPT), which is focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. This stock has been hit hard by the bears so far in 2013, with shares off by 36%.
If you take a look at the chart for TSPT, you'll notice that this stock has been trending sideways inside of a big consolidation pattern for the last three months, with shares moving between $2.71 on the downside and $3.25 on the upside. Shares of TSPT are counter-trending higher today in the face of a very weak tape. This move is starting to push the stock within range of triggering a near-term breakout trade above the upper-end of its sideways trading chart pattern.
Traders should now look for long-biased trades in TSPT if it manages to break out above its 50-day moving average at $2.91 a share and then once it takes out more near-term overhead resistance levels at $3.16 to $3.25 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 138,444 shares. If that breakout triggers soon, then TSPT will set up to re-test or possibly take out its next major overhead resistance levels at $4.23 to its 200-day at $4.39 a share. If those levels get taken out with volume, then TSPT could easily hit its next major overhead resistance levels at $5 to $5.50 a share.
Traders can look to buy TSPT off weakness to anticipate that breakout and simply use a stop that sits right below its recent low of $2.71 a share. One can also buy TSPT off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 5 Regional Bank Companies To Buy For 2014: Auxilio Inc (AUXO)
Auxilio, Inc. (Auxilio), incorporated on August 29, 1995, is engaged in the business of providing fully outsourced print management services to the healthcare industry. The Company is engaged in the business of providing fully-outsourced managed print services to the healthcare industry, working exclusively with hospitals throughout the United States. It provides solutions, a program and savings. It helps hospitals and health systems reduce expenses and create manageable, dependable document image management programs by managing their back-office processes. The process is initiated through a detailed assessment. The assessment is a strategic, operational and financial analysis that is performed at the customer�� premises using a combination of processes and technology for data collection and report generation. The Company�� customers include hospitals and integrated health delivery networks (IDN). Its subsidiaries include Auxilio Solutions, Inc. and e-Perception Technologies, Inc.
The Company helps hospitals and health systems to create image management programs by managing their back-office processes. The process is initiated through a detailed Image Management Assessment (IMA). The IMA is a strategic, operational and financial analysis that is performed at the customer�� premises using a combination of processes and Web-based technology for data collection and report generation. After the assessment and upon engagement, it charged the customer on a per print basis.
The Company competes with Xerox, Canon, Konica Minolta, Ricoh and Sharp.
Advisors' Opinion:- [By CRWE]
Today, AUXO surged (+3.26%) up +0.030 at $.950 with�200 shares in play thus far (ref. google finance Delayed: 9:30AM EDT August 23, 2013).
AUXILIO, Inc. previously reported financial results for its quarter ended June 30, 2013.
For the three months ended June 30, 2013, AUXILIO reported that recurring service revenues increased by $1.4 million from new contracts closed between May 2012 and April 2013; however revenues were $9.8 million, a decrease of 8% when compared to revenues of $10.7 million in the same period of 2012, due to a drop in equipment revenue. Equipment sales were $800,000 as compared to $3.1 million for the same period in 2012. Cost of revenues were $8.2 million for the three months ended June 30, 2013, as compared to $9.3 million for the same period in 2012. This drop was due to the drop in equipment sales offset by additional staffing and service costs from the higher recurring service revenue. Gross profit for the second quarter of 2013 was $1.6 million, or 17% of sales, compared to $1.4 million, or 13% of sales, for the same period of 2012. This improvement is a direct result of the large growth in new facilities that we added in 2012 coupled with the reduction in costs as AUXILIO�� program matures within these new accounts.
Top 5 Regional Bank Companies To Buy For 2014: Intergrative Stem Cell Holdings Inc (YFRM)
Intergrative Stem Cell Holdings Inc., formerly YaFarm Technologies, Inc., incorporated on June 16, 2006, is a Web development and Web hosting company. The Company, through its wholly owned subsidiary, YaFarm Group, LLC, offers a range of business-class Website development and Web hosting products and services for small and medium-sized businesses. The Company offers Web solutions for small- and medium- sized companies, including Web development, Web hosting, Web maintenance and business image consulting services.
The Company offers Web solution packages to small and medium-sized businesses, which includes Bronze Small Business Package, Silver Medium-Sized Business Package and Gold E-Commerce Package. The Company did not generate any revenues.
Advisors' Opinion:- [By Peter Graham]
What�� the Catch With Caribbean International Holdings? According to various disclosures, transactions of $1.5k, $2k, $3k, $3.5k, $4k, $7k, $15k and $16k have or will occur to mention Caribbean International Holdings in various investment newsletters. At the beginning of last week, Caribbean International Holdings announced that it was in the final stages of construction of a new Winghouse and Entertainment Center facility on the strip in Sosua, Dominican Republic, that feature its signature wings complemented by a variety of sauce and spice choices plus a mechanical bull. Caribbean International Holdings also recently announced it will offer Winghouse restaurant franchises (for 25,000 dollars plus a percentage of gross revenues) throughout the Caribbean as well as Central and South America. Winghouse restaurants offer 18 flavor choices with four varieties of spicy heat in a country setting with mechanical bulls as the centerpiece. Finally and last May, Caribbean International Holdings announced that ��fter three months of silence,��the merger documents between YaFarm Technologies, Inc (OTCMKTS: YFRM) and the Integrated Stem Cell Institute in Cancun, Mexico, have been signed and that CIHN now has a 12.5% stake in a company that�� been a favorite of stock promoters. However, the most updated financials that I see for Caribbean International Holdings date from June of last year on Yahoo! Finance ��and A LOT can happen within a year��
No comments:
Post a Comment